AnnouncementJanuary 7
Company Operations During COVID-19 Imposed State of Emergency in Tokyo and Three Neighboring Prefectures
Our sincere condolences to victims of COVID-19, and hopes for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals who are working at the forefront to treat patients, and everyone who is helping to support the community infrastructure.
Responding to the COVID-19-related state of emergency in the metropolitan area including Tokyo, Kanagawa, Chiba, and Saitama declared by the Japanese Government on January 7, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be closing company sites from January 8, prioritizing the safety of customers and employees. During the closure, PHC Group employees at the sites listed below will continue business operations by working from home, except in special cases where they perform essential duties that cannot be performed remotely, and will respond to customer inquiries by e-mail, phone calls, etc.
· Site closures
| PHC Holdings Corporation |
Shimbashi Headquarters (Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo) |
| PHC Corporation |
Shimbashi Headquarters (Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo)
[Biomedical Business Unit]
Tokyo Sales Office/Pharmacy System Sales Office/Delicart Sales Office (address as above)
South Kanto Sales Office (Address: 1-16-32-106 Fujigaoka, Aoba-ku, Yokohama City, Kanagawa)
[Medical Information Systems Business Unit]
East Japan Sales Office (address as above)
Shibuya Business Transformation Center (Address: Tokyo Tatemono Shibuya Building 7F, 3-9-9 Shibuya, Shibuya-ku, Tokyo)
Omiya Office (Address: Wellness Cube Omiya 3/4F, 1-853-8 Miyahara-cho, Kita-ku, Saitama City, Saitama)
[Anatomical Pathology Business Unit]
Shinkoyasu Manufacturing Site (Address: 3-9 Moriya-cho, Kanagawa-ku, Yokohama City, Kanagawa)
CS Repair Warehouse (Address: 3-22-16 Nishikojiya, Ota-ku, Tokyo) |
| Shonan Health Innovation Park Office (Address: Shonan Health Innovation Park B33F-4110, 34-10 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa) |
Details of additional upcoming measures will be announced respectively by each business unit in charge, where appropriate. Resuming of operations at these sites will be considered depending on government policies and the status of the COVID-19. We appreciate your understanding and apologize for any inconvenience or disruption that you may experience.
Other PHC Corporation sites in Japan will continue operations as usual at their offices, plants, etc. Details for other PHC Group companies will be announced separately and we ask you to refer to each company's website for further information.
The PHC Group has already implemented measures such as teleworking and videoconferencing to minimize the infection risk for customers and employees. The health and safety of our customers, patients, employees and their families are most important to us and we will continue to further strengthen measures to prevent internal and external spread of the infection, while working to ensure stable supply for customers and patients who rely on our products and services.